The inventor and developer of the semi-bioabsorbable Silhouette Mid-face Suture™ for soft tissue in the aesthetic and plastic and reconstructive surgery markets, announced that it has received Australian TGA approval for the Silhouette Mid-face Suture™ device.
The Silhouette Mid-face Suture™device received FDA clearance in October 2006, CE Marking in January of 2007, and is pending approval in Korea and a other countries.
The device will be exclusively distributed in Australia by Austramedex.
Austramedex is the leading Australian company for the marketing and distribution of many aesthetic surgery products.
The product is the first in a series of Silhouette suture products with various “indications for use” that we plan to introduce over the next twelve months that will enable us to continue to meet the needs of our surgeon customers in the plastic surgery market.
Current trials are underway that are designed to determine the use and effectiveness of the device in the brow, breast and abdomen of patients and also separate studies are being conducted for wound closure applications.